title: Evaluation of anti-Moraxella bovis pili immunoglobulin-A in tears following intranasal vaccination of cattle.
abstract: Infectious bovine keratoconjunctivitis (IBK) is a highly contagious ocular disease of cattle caused by Moraxella bovis (Mb). Parenterally administered immunogens used to prevent the disease do not offer complete protection possibly because they stimulate a poor ocular mucosal secretory response, in which locally secreted immunoglobulin-A (sIgA) is one of the main components. The principal aim of this study was to evaluate by an indirect enzyme linked immunosorbent assay (ELISA), the local ocular mucosal sIgA response against Mb purified pili, produced after intranasal inoculation of experimental vaccines. Pili were adjuvanted by several different adjuvants (QuilA, Marcol Arlacel, Marcol Span, microencapsulated pili with PLGA polymers). Results were compared to sIgA response produced by adjuvant placebo inoculations and by IBK natural infection. Significantly higher anti-pili IgA response (p<0.05) was detected in calves vaccinated intranasally with pili QuilA and pili Marcol Span compared to control calves, although this specific immune response did not seem to be related to protection against Mb infection or typical IBK lesion development.
authors.affiliation: Departamento de Salud Pública Veterinaria, Facultad de Ciencias Veterinarias, Universidad Nacional del Litoral, Kreder 2805, Esperanza, C.P. S3080HOF, Provincia de Santa Fe, Argentina. virginiazbrun@yahoo.com.ar
authors.forename: M V
authors.initials: MV
authors.lastname: Zbrun
authors.forename: G C
authors.initials: GC
authors.lastname: Zielinski
authors.forename: H C
authors.initials: HC
authors.lastname: Piscitelli
authors.forename: C
authors.initials: C
authors.lastname: Descarga
authors.forename: L A
authors.initials: LA
authors.lastname: Urbani
authors.forename: M V
authors.initials: MV
authors.lastname: Defain Tesoriero
authors.forename: L
authors.initials: L
authors.lastname: Hermida
mesh_terms: D000281:Administration, Intranasal; D000818:Animals; D000907:Antibodies, Bacterial / Q000032:analysis* / Q000276:immunology; D001428:Bacterial Vaccines / Q000008:administration & dosage / Q000276:immunology* / Q000627:therapeutic use; D002417:Cattle; D004306:Dose-Response Relationship, Immunologic; D004797:Enzyme-Linked Immunosorbent Assay / Q000662:veterinary; D010861:Fimbriae, Bacterial / Q000276:immunology*; D007070:Immunoglobulin A / Q000032:analysis* / Q000276:immunology; D016955:Moraxella bovis / Q000276:immunology*; D045828:Moraxellaceae Infections / Q000276:immunology / Q000517:prevention & control / Q000662:veterinary*; D013666:Tears / Q000276:immunology*; D014611:Vaccination / Q000379:methods / Q000662:veterinary
chemical_list: D000907:Antibodies, Bacterial; D001428:Bacterial Vaccines; D007070:Immunoglobulin A